Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366261625> ?p ?o ?g. }
- W4366261625 endingPage "336" @default.
- W4366261625 startingPage "327" @default.
- W4366261625 abstract "Atherosclerosis is a chronic inflammatory disease that is characterized by the build-up of lipid-rich plaques in the arterial walls. The standard treatment for patients with atherosclerosis is statin therapy aimed to lower serum lipid levels. Despite its widespread use, many patients taking statins continue to experience acute events. Thus, to develop improved and alternative therapies, we previously reported on microRNA-145 (miR-145 micelles) and its ability to inhibit atherosclerosis by targeting vascular smooth muscle cells (VSMCs). Importantly, one dose of miR-145 micelles significantly abrogated disease progression when evaluated two weeks post-administration. Thus, in this study, to evaluate how long the sustained effects of miR-145 micelles can be maintained and towards identifying a dosing regimen that is practical for patients with chronic disease, the therapeutic effects of a single dose of miR-145 micelles were evaluated for up to two months in vivo. After one and two months post-treatment, miR-145 micelles were found to reduce plaque size and overall lesion area compared to all other controls including statins without causing adverse effects. Furthermore, a single dose of miR-145 micelle treatment inhibited VSMC transdifferentiation into pathogenic macrophage-like and osteogenic cells in plaques. Together, our data shows the long-term efficacy and sustained effects of miR-145 micelles that is amenable using a dosing frequency relevant to chronic disease patients." @default.
- W4366261625 created "2023-04-20" @default.
- W4366261625 creator A5056582120 @default.
- W4366261625 creator A5063256253 @default.
- W4366261625 creator A5073755090 @default.
- W4366261625 creator A5084822953 @default.
- W4366261625 creator A5088677255 @default.
- W4366261625 creator A5091479045 @default.
- W4366261625 date "2023-09-01" @default.
- W4366261625 modified "2023-10-15" @default.
- W4366261625 title "Long-term, in vivo therapeutic effects of a single dose of miR-145 micelles for atherosclerosis" @default.
- W4366261625 cites W1970183428 @default.
- W4366261625 cites W1973364296 @default.
- W4366261625 cites W1975968199 @default.
- W4366261625 cites W1983946999 @default.
- W4366261625 cites W1988532263 @default.
- W4366261625 cites W1990612961 @default.
- W4366261625 cites W1992717547 @default.
- W4366261625 cites W2001330601 @default.
- W4366261625 cites W2014346055 @default.
- W4366261625 cites W2017886856 @default.
- W4366261625 cites W2070103818 @default.
- W4366261625 cites W2094212146 @default.
- W4366261625 cites W2094737433 @default.
- W4366261625 cites W2106734896 @default.
- W4366261625 cites W2112360098 @default.
- W4366261625 cites W2115169717 @default.
- W4366261625 cites W2118105142 @default.
- W4366261625 cites W2122234255 @default.
- W4366261625 cites W2123740493 @default.
- W4366261625 cites W2137983259 @default.
- W4366261625 cites W2141814949 @default.
- W4366261625 cites W2145195851 @default.
- W4366261625 cites W2149307753 @default.
- W4366261625 cites W2150949973 @default.
- W4366261625 cites W2151247869 @default.
- W4366261625 cites W2153749888 @default.
- W4366261625 cites W2158712961 @default.
- W4366261625 cites W2159616443 @default.
- W4366261625 cites W2167976457 @default.
- W4366261625 cites W2247997571 @default.
- W4366261625 cites W2279717914 @default.
- W4366261625 cites W2496801530 @default.
- W4366261625 cites W2525459565 @default.
- W4366261625 cites W2548599454 @default.
- W4366261625 cites W2565800876 @default.
- W4366261625 cites W2595169180 @default.
- W4366261625 cites W2737249697 @default.
- W4366261625 cites W2757664723 @default.
- W4366261625 cites W2762257317 @default.
- W4366261625 cites W2762302677 @default.
- W4366261625 cites W2765682742 @default.
- W4366261625 cites W2776306725 @default.
- W4366261625 cites W2783298701 @default.
- W4366261625 cites W2790654167 @default.
- W4366261625 cites W2810909862 @default.
- W4366261625 cites W2893168313 @default.
- W4366261625 cites W2921012991 @default.
- W4366261625 cites W2923928888 @default.
- W4366261625 cites W2955108563 @default.
- W4366261625 cites W2976010525 @default.
- W4366261625 cites W2984766121 @default.
- W4366261625 cites W3037994711 @default.
- W4366261625 cites W3042705713 @default.
- W4366261625 cites W3092305767 @default.
- W4366261625 cites W3103761932 @default.
- W4366261625 cites W3106443431 @default.
- W4366261625 cites W3126426815 @default.
- W4366261625 cites W3127304884 @default.
- W4366261625 cites W3154052361 @default.
- W4366261625 cites W3181183321 @default.
- W4366261625 cites W3185893654 @default.
- W4366261625 cites W4214669202 @default.
- W4366261625 cites W4282934787 @default.
- W4366261625 doi "https://doi.org/10.1016/j.bioactmat.2023.04.001" @default.
- W4366261625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37122900" @default.
- W4366261625 hasPublicationYear "2023" @default.
- W4366261625 type Work @default.
- W4366261625 citedByCount "1" @default.
- W4366261625 countsByYear W43662616252023 @default.
- W4366261625 crossrefType "journal-article" @default.
- W4366261625 hasAuthorship W4366261625A5056582120 @default.
- W4366261625 hasAuthorship W4366261625A5063256253 @default.
- W4366261625 hasAuthorship W4366261625A5073755090 @default.
- W4366261625 hasAuthorship W4366261625A5084822953 @default.
- W4366261625 hasAuthorship W4366261625A5088677255 @default.
- W4366261625 hasAuthorship W4366261625A5091479045 @default.
- W4366261625 hasBestOaLocation W43662616251 @default.
- W4366261625 hasConcept C102652120 @default.
- W4366261625 hasConcept C11268172 @default.
- W4366261625 hasConcept C126322002 @default.
- W4366261625 hasConcept C147789679 @default.
- W4366261625 hasConcept C150903083 @default.
- W4366261625 hasConcept C184651966 @default.
- W4366261625 hasConcept C185592680 @default.
- W4366261625 hasConcept C197934379 @default.
- W4366261625 hasConcept C202751555 @default.
- W4366261625 hasConcept C207001950 @default.